Meridian Bioscience (VIVO) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $4.94 +1.44%
Financial Fact:
Common share options: -897K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Common share options: -897K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Meridian Bioscience (NASDAQ: VIVO) reported Q1 EPS of $0.24, in-line with the analyst estimate of $0.24. Revenue for the quarter came in at $51.55 million versus the consensus estimate of $50.5 million.
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Femasys Inc. (FEMY) Misses Q2 EPS by 20c
- BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
